FDA Clearance Tracker · P150030-S045
R3 Delta Ceramic Hip System
Last checked: Nov 20, 2026Latest source record: Feb 28, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Feb 28, 2025
Approved
Time to decision
178 days
Received Sep 3, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150030-S045
- Device name
- R3 Delta Ceramic Hip System
- Applicant
- Smith & Nephew, Inc.
- Applicant location
- Memphis, TN
- Received
- Sep 3, 2024
- Decided
- Feb 28, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P150030
Device type
- Device type
- Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for revisions to device labeling that was updated to include information on the Post-Approval Study (PAS), Short to Mid-term f/u of New US patients PAS, for the R3 Delta Ceramic Hip System.
Source documents
Other decisions for Smith & Nephew, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Tendon Anchor510(k)
K263461 · Decided Oct 27, 2026 · 29 days after receipt
Device type: Staple, Implantable (GDW) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.